Year ended | Year ended | ||||||
30 June 2025 | 30 June 2024 | ||||||
Revenue | Capital | Total | Revenue | Capital | Total | ||
Notes | £ | £ | £ | £ | £ | £ | |
(Losses)/gains on investments | |||||||
at fair value through profit or loss | 8 | ( | ( | ||||
Exchange losses on capital | |||||||
items | ( | ( | ( | ( | |||
Investment income | 2 | ||||||
Investment management fee | 3 | ||||||
Other expenses | 4 | ( | ( | ( | ( | ||
(Loss)/return before taxation | ( | ( | ( | ||||
Taxation | 5 | ( | ( | ( | ( | ||
Net (loss)/return after taxation | ( | ( | ( | ||||
Revenue | Capital | Total | Revenue | Capital | Total | ||
pence | pence | pence | pence | pence | pence | ||
(Loss)/return after taxation | |||||||
per 10p (2024: 50p) ordinary | |||||||
share – basic & diluted | 6 | ( | ( | ( |
Ordinary | Capital | ||||||
share | Share | redemption | Special | Capital | Revenue | ||
capital | premium | reserve | reserve | reserve | reserve | Total | |
£ | £ | £ | £ | £ | £ | £ | |
Balance at 1 July 2024 | ( | ||||||
Total comprehensive income | |||||||
Net loss for the year | ( | ( | ( | ||||
Transactions with Shareholders recorded | |||||||
directly to equity | |||||||
Transfer between reserves on deconsolidation of NCT | ( | ||||||
Ordinary dividends | |||||||
Balance at 30 June 2025 | |||||||
Balance at 1 July 2023 | ( | ||||||
Total comprehensive income | |||||||
Net return for the year | |||||||
Transactions with Shareholders | |||||||
recorded | |||||||
directly to equity | |||||||
Cancellation of share | |||||||
premium account and capital redemption | |||||||
reserve | ( | ( | |||||
Share issue | |||||||
Cost of shares | |||||||
purchased under Tender Offer and held in Treasury | ( | ( | ( | ||||
Tender Offer costs | ( | ( | |||||
Ordinary dividends | |||||||
Balance at 30 June 2024 | ( |
30 June | 30 June | ||
2025 | 2024 | ||
£ | £ | ||
Non-current assets | |||
Investments held at fair value through profit or loss | 8 | ||
Current assets | |||
Trade and other receivables | 11 | ||
Cash and cash equivalents | |||
Current liabilities | |||
Trade and other payables | 12 | ( | ( |
( | ( | ||
Net current assets | |||
Net assets | |||
Capital and reserves | |||
Ordinary share capital | 13 | ||
Share premium | |||
Capital reserve | |||
Revenue reserve | ( | ||
Shareholders' funds | |||
NAV per 10p ordinary share | 15 | # |
30 June | 30 June | 30 June | 30 June | ||
2025 | 2024 | 2025 | 2024 | ||
Notes | £ | £ | £ | £ | |
Cash flows used in operating activities | |||||
Income received from investments | 147,778 | 269,318 | |||
Interest received | 4,443 | 50,706 | |||
Overseas taxation paid | ( | ( | (1,043) | (4,475) | |
Investment management fees paid | – | – | |||
Other cash payments | ( | ( | (392,246) | (339,205) | |
Net cash used in operating activities | ( | ( | (241,068) | (23,656) | |
Cash flows used in financing activities | |||||
Proceeds from Share Issue | – | 3,618,690 | |||
Funding of Tender Offer | ( | – | (13,445,091) | ||
Tender Offer expenses paid | ( | – | (539,075) | ||
Net cash used in financing activities | ( | – | (10,365,476) | ||
Cash flows generated from investing activities | |||||
Purchase of investments | 8 | ( | ( | (3,386,658) | (9,459,505) |
Sale of investments | 8 | 3,968,583 | 11,831,583 | ||
Contribution to subsidiaries | (8,306) | (13,080) | |||
Net cash generated from investing activities | 573,619 | 2,358,998 | |||
Net increase/(decrease) in cash and cash equivalents | ( | 332,551 | (8,030,134) | ||
Reconciliation of net cash flow to movement in net cash | |||||
Increase/(decrease) in cash | ( | 332,551 | (8,030,134) | ||
Exchange rate movements | – | – | |||
Increase/(decrease) in net cash | ( | 332,551 | (8,030,134) | ||
Net cash at start of period | 251,625 | 8,281,759 | |||
Net cash at end of period | 584,176 | 251,625 | |||
Analysis of net cash | |||||
Cash and cash equivalents | 584,176 | 251,625 | |||
584,176 | 251,625 |
Year ended | Year ended | |||||
30 June 2025 | 30 June 2024 | |||||
Revenue | Capital | Total | Revenue | Capital | Total | |
£ | £ | £ | £ | £ | £ | |
Income from investments: | ||||||
UK dividends | 137,176 | 3,750 | 140,926 | 122,596 | 118,536 | 241,132 |
Unfranked dividend income | ||||||
(including scrip dividends) | 7,412 | – | 7,412 | 13,548 | – | 13,548 |
UK fixed interest | – | – | – | 23,188 | – | 23,188 |
144,588 | 3,750 | 148,338 | 159,332 | 118,536 | 277,868 | |
Other income | ||||||
Bank deposit and other interest | 4,445 | – | 4,445 | 50,708 | – | 50,708 |
Total income | 149,033 | 3,750 | 152,783 | 210,040 | 118,536 | 328,576 |
Year ended | Year ended | |
30 June | 30 June | |
2025 | 2024 | |
£ | £ | |
Investment management fee | – | – |
Year ended | Year ended | |
30 June | 30 June | |
2025 | 2024 | |
£ | £ | |
Administration and secretarial services | 85,000 | 85,000 |
Auditor's remuneration for: | ||
– audit of the Group's financial statements | 52,500 | 50,000 |
Directors' remuneration (see Note 18) | 60,000 | 61,667 |
Investment Manager's contribution to expenses (see Note 3) | (224,059) | (189,476) |
Capital expenses | (24,744) | – |
Other expenses | 176,631 | 181,041 |
Total expenses | 125,328 | 188,232 |
Year ended 30 June 2025 | Year ended 30 June 2024 | |||||
Revenue | Capital | Total | Revenue | Capital | Total | |
£ | £ | £ | £ | £ | £ | |
Current Taxation | – | – | – | – | – | – |
Overseas taxation suffered | 1,049 | – | 1,049 | 3,629 | – | 3,629 |
1,049 | – | 1,049 | 3,629 | – | 3,629 |
Year ended 30 June 2025 | Year ended 30 June 2024 | |||||
Revenue | Capital | Total | Revenue | Capital | Total | |
£ | £ | £ | £ | £ | £ | |
(Loss)/return on ordinary | ||||||
activities | (1,039) | (69,386) | (70,425) | 21,808 | 994,467 | 1,016,275 |
Tax at UK Corporation tax | ||||||
rate of 25.0% (2024: 25.0%) | (260) | (17,346) | (17,606) | 5,452 | 248,617 | 254,069 |
Effects of: | ||||||
UK dividends that are not taxable | (34,294) | (938) | (35,232) | (30,649) | (29,634) | (60,283) |
Overseas dividends that are not taxable | – | – | – | – | – | – |
Non-taxable investment | ||||||
losses/(gains) | – | 24,470 | 24,470 | – | (218,983) | (218,983) |
Overseas taxation suffered | 1,049 | – | 1,049 | 3,629 | – | 3,629 |
Unrelieved expenses | 34,554 | (6,186) | 28,368 | 25,197 | – | 25,197 |
Actual current tax charged | ||||||
to the revenue account | 1,049 | – | 1,049 | 3,629 | – | 3,629 |
Year ended | Year ended | |||||
30 June 2025 | 30 June 2024 | |||||
Revenue | Capital | Total | Revenue | Capital | Total | |
(Loss)/return after taxation | ||||||
attributable to ordinary | ||||||
Shareholders (£) | (2,088) | (69,386) | (71,474) | 18,179 | 994,467 | 1,012,646 |
Weighted average number | ||||||
of ordinary shares in issue | ||||||
(excluding shares held in Treasury) | 9,186,025 | 2,045,691 | ||||
(Loss)/return per ordinary | ||||||
share basic and diluted | ||||||
(pence) | (0.02) | (0.76) | (0.78) | 0.89 | 48.61 | 49.50 |
Year ended | Year ended | |
30 June | 30 June | |
2025 | 2024 | |
£ | £ | |
Unclaimed dividends in respect of prior periods | ||
clawed back after 12 years | 8,468 | 1,927 |
Total | 8,468 | 1,927 |
Group | Company | |||
2025 | 2024 | 2025 | 2024 | |
£ | £ | £ | £ | |
Investments held at fair value through profit or loss | ||||
Opening book cost | 6,286,746 | 8,123,670 | 6,286,746 | 8,177,670 |
Opening net investment holding gains | 783,074 | 440,800 | 783,074 | 386,800 |
Opening valuation | 7,069,820 | 8,564,470 | 7,069,820 | 8,564,470 |
Movements in the year: | ||||
Purchases at cost | 3,377,072 | 9,504,441 | 3,377,072 | 9,504,441 |
Sales proceeds | (3,989,455) | (11,885,506) | (3,989,455) | (11,885,503) |
Realised gains on sales | 585,135 | 544,141 | 585,135 | 490,138 |
Unrealised (losses)/gains in the year | (683,014) | 342,274 | (683,014) | 396,274 |
Closing valuation | 6,359,558 | 7,069,820 | 6,359,558 | 7,069,820 |
Being: | ||||
Book cost | 6,259,498 | 6,286,746 | 6,259,498 | 6,286,746 |
Net investment holding gains | 100,060 | 783,074 | 100,060 | 783,074 |
6,359,558 | 7,069,820 | 6,359,558 | 7,069,820 |
Group | Company | |||
2025 | 2024 | 2025 | 2024 | |
£ | £ | £ | £ | |
Summary of capital gains | ||||
Realised gains on sales | 585,135 | 544,141 | 585,135 | 490,138 |
Unrealised (losses)/gains in the year | (683,014) | 342,274 | (683,014) | 396,274 |
(97,879) | 886,415 | (97,879) | 886,412 |
Group | Company | |||
2025 | 2024 | 2025 | 2024 | |
£ | £ | £ | £ | |
Transaction costs | ||||
Costs on purchases | 9,208 | 32,920 | 9,208 | 32,920 |
Costs on sales | 4,894 | 39,595 | 4,894 | 39,595 |
14,102 | 72,515 | 14,102 | 72,515 |
Group | Level 1 | Level 2 | Level 3 | Total |
At 30 June 2025 | £ | £ | £ | £ |
Financial assets at fair value through profit or loss: | ||||
Equities | 6,359,558 | – | – | 6,359,558 |
6,359,558 | – | – | 6,359,558 | |
Group | Level 1 | Level 2 | Level 3 | Total |
At 30 June 2024 | £ | £ | £ | £ |
Financial assets at fair value through profit or loss: | ||||
Equities | 7,069,820 | – | – | 7,069,820 |
7,069,820 | – | – | 7,069,820 |
Company | Company | |||
30 June 2025 | 30 June 2024 | |||
New Centurion Trust | Abport | Total | Total | |
£ | £ | £ | £ | |
At 1 June 2024 | 5,406,679 | 3,873 | 5,410,552 | 5,410,552 |
Provision for diminution | ||||
brought forward | (4,599,852) | (3,204) | (4,603,056) | (4,603,056) |
806,827 | 669 | 807,496 | 807,496 | |
In specie distribution from NCT 15 June 2025 | (806,827) | – | (806,827) | – |
Received from Abport | ||||
Limited | – | (669) | (669) | – |
Value at 30 June 2025 | – | – | – | 807,496 |
Country of | % share of | % share of | ||
Incorporation | capital held | voting rights | Nature of business | |
Abport Limited | England | 100% | 100% | Investment dealing company |
Group | Company | |||
2025 | 2024 | 2025 | 2024 | |
£ | £ | £ | £ | |
Amounts due from subsidiaries | – | – | – | 53,849 |
Dividends receivable | 15,055 | 14,495 | 15,055 | 14,495 |
Trade receivables | 35,839 | 43,439 | 35,839 | 43,439 |
Other receivables | 431,946 | 206,992 | 431,946 | 206,992 |
482,840 | 264,926 | 482,840 | 318,775 |
Group | Company | |||
2025 | 2024 | 2025 | 2024 | |
£ | £ | £ | £ | |
Trade payables | 6,881 | 44,936 | 6,881 | 44,936 |
Other accruals | 105,958 | 165,362 | 105,958 | 158,280 |
112,839 | 210,298 | 112,839 | 203,216 |
Group and Company | Group and Company | |||
2025 | 2024 | |||
Number | £ | Number | £ | |
Issued allotted and fully paid: | ||||
Ordinary shares of 10p each (2024: 50p each) | 27,924,390 | 2,792,439 | 5,584,878 | 2,792,439 |
Group | Company | |||
2025 | 2024 | 2025 | 2024 | |
£ | £ | £ | £ | |
Issued preference share of 50p each | – | – | – | 858,783 |
2024 | ||
2025 | (restated) # | |
£ | £ | |
Net Assets | 7,313,735 | 7,376,741 |
Ordinary shares in issue (excluding Treasury shares) | 9,186,025 | 9,186,025 |
NAV per ordinary share | 79.62p | 80.30p |
2025 | 2024 | |
(Book and | (Book and | |
fair value) | fair value) | |
Assets at fair value through profit or loss: | ||
Investment portfolio | 6,359,558 | 7,069,820 |
Loans and receivables | ||
Trades for future settlement | 35,839 | 43,436 |
Accrued income | 15,055 | 14,495 |
Other debtors | 424,238 | 199,295 |
Cash at bank | 584,176 | 252,293 |
Liabilities at amortised cost or equivalent | ||
Trades for future settlement | (6,881) | (44,936) |
Creditors (including unclaimed dividends) | (105,958) | (165,362) |
Total for financial instruments | 7,306,027 | 7,369,041 |
Non-financial instruments | 7,708 | 7,700 |
Total net assets | 7,313,735 | 7,376,741 |
Group | Company | |||
2025 | 2024 | 2025 | 2024 | |
£ | £ | £ | £ | |
Financial assets neither past due or impaired | ||||
Trade and other receivables | 475,132 | 257,226 | 475,132 | 311,075 |
Cash and cash equivalents | 584,176 | 252,293 | 584,176 | 251,625 |
1,059,308 | 509,519 | 1,059,308 | 562,700 |